374 results on '"Nishiyama, Kazutoshi"'
Search Results
2. Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial
3. Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis
4. Cholesterol crystal embolism-related cerebral infarction: Magnetic resonance imaging and clinical characteristics
5. H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay
6. H-Intensity Scale (HIS) Score for Estimation of CSF GluN1 Antibody Titers with One-Time Immunostaining using a Commercial Assay (P5-14.002)
7. Asymptomatic acute ischemic lesions in intracerebral hemorrhage: Its frequency, MRI features, and risk factors
8. The influence of right-left error in the placement of the Cc electrode in tibial nerve somatosensory evoked potentials (SEPs)
9. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration
10. HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data
11. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial
12. Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases
13. A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features
14. Correction of collimator-dependent differences in the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging: Determination of conversion equations using point-source imaging
15. Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations
16. Novel De Novo KCND3 Mutation in a Japanese Patient with Intellectual Disability, Cerebellar Ataxia, Myoclonus, and Dystonia
17. Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis
18. Screening for Imprinted Genes by Allelic Message Display: Identification of a Paternally Expressed Gene Impact on Mouse Chromosome 18
19. Clinical significance and limitations of Commercial Rat Brain Immunohistochemistry as a Screening Test for Neuronal Surface Antibodies (P4-5.008)
20. Neuronal surface antigen-specific immunostaining pattern on a rat brain immunohistochemistry in autoimmune encephalitis
21. Protocol for Cerebral Microbleeds during the Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial
22. An improved method for estimating the heart-to-mediastinum ratio from cardiac sympathetic nerve imaging with low-energy high-resolution collimators
23. Septal penetration in iodine-123 metaiodobenzylguanidine cardiac sympathetic imaging using a medium-energy collimator
24. Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy
25. Markers for Guillain‐Barré syndrome with poor prognosis: a multi‐center study
26. A clinical predictive score for postoperative myasthenic crisis
27. Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial
28. Correction to: A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features
29. Characterization of Neuronal Surface Antigen-Specific Immunostaining Pattern: Comparison between In-house and Commercial Brain Immunohistochemistry (P1-1.Virtual)
30. Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study
31. Immunotherapy-responsive recurrent extensive white matter disease without neuronal or glial surface antibodies: A case report
32. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation
33. Abnormal myocardial scintigraphy in a GTP cyclohydrolase 1 mutation carrier with Parkinsonʼs disease
34. A phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis: Induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (IDREAM) study
35. Loss of DARPP-32 and calbindin in multiple system atrophy
36. Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke A Randomized Clinical Trial and Meta-analysis
37. Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis
38. I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway
39. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI-NVAF Study
40. Biphasic neurovascular changes in prolonged migraine aura in familial hemiplegic migraine type 2
41. AP-VAS 2012 case report: a case of systemic MPO-ANCA-associated vasculitis that demonstrated brain infarction and immunohistochemically MPO-positive capillaries
42. Status epilepticus suspected autoimmune: Neuronal surface antibodies and main clinical features
43. P-MD008. Differential effects of thyrotropin releasing hormone on motor performance and motor adaptation in patients with spinocerebellar degeneration
44. Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis
45. A case of primary progressive multiple sclerosis (PPMS) that caused acute exacerbation after 15th year from the onset
46. A case of anti-MuSK antibody positive myasthenia gravis with tongue atrophy improving by potent immunotherapy in a short period
47. Reliability and validity of Japanese version of Fugl-Meyer assessment for the lower extremities
48. Lewy Body Pathology in a Patient With a Homozygous Parkin Deletion
49. Reliability and validity of Japanese version of Fugl-Meyer assessment for the lower extremities.
50. An autopsy case of MM2-thalamic subtype of sporadic Creutzfeldt-Jakob disease with Lewy bodies presenting as a sleep disorder mimicking anti-IgLON5 disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.